-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Upgrades Guardant Health to Outperform, Raises Price Target to $160

Benzinga·06/02/2026 10:41:54
Listen to the news
Evercore ISI Group analyst Vijay Kumar upgrades Guardant Health (NASDAQ:GH) from In-Line to Outperform and raises the price target from $95 to $160.